CLX Investment Company Announces First Diagnostic Test Order for Zonda, Inc. in Holland and Belgium.TEMECULA, Calif. -- CLX (library, graphics) CLX - The Common Lisp library providing a low-level interface to the X Window System, equivalent to Xlib. Graphics toolkits can be built on top of CLX, e.g. McCLIM, Garnet, CLUE and CLIO. Investment Company (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CLXN) today announced that portfolio company Zonda, Inc., which specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets, has received the first order for its HandiLab-C Chlamydia chlamydia (kləmĭd`ēə), genus of microorganisms that cause a variety of diseases in humans and other animals. Psittacosis, or parrot fever, caused by the species Chlamydia psittaci, test for Holland and Belgium. The order for the over-the-counter version of the HandiLab-C test, which will be distributed to pharmacies and other retail locations throughout Holland and Belgium, will be shipped along with re-orders that were recently placed for Swedish and Norwegian pharmacies. Zonda's HandiLab-C test is the only over-the-counter Chlamydia test that carries the CE mark, signifying Signifyin' (slang) is an African-American rhetorical device featuring indirect communication or persuasion and the creating of new meanings for old words and signs. Signifying, in this sense, includes repetition and difference, implication and association, combining words and that the product complies with the relevant health, safety, environmental protection requirements in Europe and can therefore be legally placed on the market. "With the addition of Belgium and Holland, the distribution of Zonda's products continues to grow, as do the revenues from the sale of these products across Europe," commented Tammy D. Dunn, chief executive officer of CLX Investment Company. "We are extremely pleased with the progress that has been made with expanding product distribution in a relatively short period of time and look forward to additional countries being supplied with Zonda testing products over the coming quarters." Zonda, Inc. has recently placed a standing order with its manufacturer for monthly production of the HandiLab-C test, lowering the per unit production price of the Chlamydia test and guaranteeing the timely availability of the finished product. "While we continue to assign a very conservative portfolio value to our equity position in Zonda, Inc., the growth of sales and increase in revenues are expected to significantly impact Zonda's value both as a portfolio investment and as a potential acquisition for major medical supply companies," said Ms. Dunn "Because Zonda's product line includes a variety of testing products for a number of separate and distinct markets, CLX is planning to provide more detailed information on each of Zonda's products in the March edition of our monthly newsletter. We expect to issue the March newsletter later this week," Ms. Dunn added. To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.asp. About Zonda, Inc. Zonda, Inc., in which CLX holds a 31% equity interest, is expanding the distribution of its product lines into broader markets around the world. The company's product line includes innovative, rapid, self-contained diagnostic devices for the detection of Chlamydia, gonorrhea gonorrhea (gŏnərē`ə), common infectious disease caused by a bacterium (Neisseria gonorrhoeae), involving chiefly the mucous membranes of the genitourinary tract. , yeast yeast, name applied specifically to a certain group of microscopic fungi and to commercial products consisting of masses of dried yeast cells or of yeast mixed with a starchy material and pressed into yeast cakes. and Strep A. The Chlamydia test is currently being distributed in an expanding number of European countries and carries a CE mark for both professional point-of-care and over-the-counter use. The gonorrhea, yeast and Strep A tests carry CE marks for professional point-of-care use, and Zonda is seeking similar approvals for over-the-counter sales of these products. Each of the Zonda infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. tests are marketed as superior to their competition due to their comparable accuracy (compared directly to PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) or DNA testing DNA testing Analysis of DNA (the genetic component of cells) in order to determine changes in genes that may indicate a specific disorder. Mentioned in: Acoustic Neuroma, Retinoblastoma, Von Willebrand Disease ), ease of use, compact design, long shelf life, rapid results, and cost effectiveness. About the Company CLX Investment Company (www.clxinvestments.com) holds a 31% equity interest in Zonda, Inc. (www.zondainc.com), a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. that specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets. Also in the CLX investment portfolio is a 49% interest in eStrategy Solutions, Inc. (www.clxinvestments.com/estrategysolutions), a Texas-based e-learning provider that has developed online training solutions for government entities and other professional organizations. CLX has invested, and holds a common stock position, in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling (chat, games) scrolling - To flood a chat room or Internet game with text or macros in an attempt to annoy the occupants. This can often cause the chat room to be "uninhabitable" due to the "noise" created by the scroller. Compare spam. advertising billboards. CLX has elected to be regulated as a Business Development Company pursuant to Section 54 of the Investment Company Act of 1940, and is pursuing a business plan wherein where·in adv. In what way; how: Wherein have we sinned? conj. 1. In which location; where: the country wherein those people live. 2. the Company seeks to make investment in developing companies with the goal of providing return for its shareholders. All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investment's control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion